Carcinogenesis in Lewis Rats Injected at Birth with DMBA
Author Information
Author(s): B. Toth, P. Shubik
Primary Institution: Chicago Medical School, Institute of Medical Research, Division of Oncology
Hypothesis
What is the effect of DMBA when administered subcutaneously at birth in Lewis rats?
Conclusion
The study found that DMBA induces subcutaneous sarcomas in Lewis rats when injected at birth, with a clear dose-response relationship.
Supporting Evidence
- DMBA was found to be a potent leukaemogenic agent for mice when injected at birth.
- Subcutaneous administration of DMBA in adult rats induces mainly sarcomas.
- Only the 1000 µg dose of DMBA significantly reduced survival rates.
- Decreasing doses of DMBA resulted in a gradual prolongation of latent periods of induced sarcomas.
- Two malignant lymphomas were observed in treated rats, none in controls.
Takeaway
When baby rats are given a chemical called DMBA, it can make them develop tumors, especially if they get a lot of it.
Methodology
Newborn Lewis rats were injected with varying doses of DMBA and monitored for tumor development and survival rates.
Limitations
The number of animals in some treatment groups was too small for quantitative evaluation of tumor incidence.
Participant Demographics
Lewis inbred rats, bred in the laboratory.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website